Overall, feedback suggests Brello Health is seen as a useful digital healthcare option, with individual experiences varying based on expectations and needs
If you choose a drop product, you're essentially relying on unproven delivery mechanics, whereas both injectable and oral formulations have FDA-backed pharmacokinetic data
Direct-to-consumer startups like Noom, Found, and Hims & Hers jumped in to fill that gap, many pivoting to prescribe compounded GLP-1s for under $200 a montha fraction of the out-of-pocket cost for the brand-name alternatives
Emerging evidence suggests that PRLMs suppress pathological vessel formation through diverse molecular pathways, offering a complementary and potentially more sustainable strategy for tumor control [222, 223]
We identified patents and their patent family members that could either be used to deter other branded competitors from upstream research and development of competing similar products (e.g., me-too versions), or which could be used downstream to block/delay generic entrants
